Here are relevant reports on : pattern-recognition-market
-
Smart Microgrid Market by Type (Hybrid, Off-Grid, Grid Connected), Component (Storage, Inverter), Power Technology (Fuel Cell, CHP), Consumer Pattern (Urban, Rural), Application (Campus, Commercial, Defense), and Geography – Global Forecast to 2022
Smart microgrids are modern, miniature versions of today’s huge centralized electricity system. Similar to a centralized grid, microgrids can generate, distribute and regulate the flow of electricity to consumers. They also can be networked with one another as well as with the central grid to increase the capacity, reliability and efficiency of the overall system. Microgrids are not necessarily owned or run by a utility company. They can be built, owned and operated by a community, neighborhood, university, corporation, hospital, individual or any other entity that has legal authority over their power infrastructure (i.e., power lines, generation source, meters, etc.).
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
APAC Injectable Drug Delivery Market by Product (Device, Autoinjectors, Formulation, Suspensions, Nanoparticles), Site of Administration (Dermal, Organ), Formulation Packaging (Ampoules, Vials), Usage Pattern (Curative, Immunization) - Forecast to 2031
The APAC injectable drug delivery market, valued at US$161.32 billion in 2025, stood at US$176.96 billion in 2026 and is projected to advance at a resilient CAGR of 9.8% from 2026 to 2031, culminating in a forecasted valuation of US$282.22 billion by the end of the period.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Osteoarthritis Therapeutics Market by Anatomy (Knee, Hand), Drug Type (NSAIDs, Analgesics, Corticosteroids), Route of Administration (Parenteral), Distribution Channel (Hospital Pharmacies), Purchasing Pattern (Prescription Drugs) - Global Forecasts to 2025
The global osteoarthritis therapeutics market growth is primed to transition from USD 7.3 billion in 2020 to USD 11.0 million by 2025, showcasing a strong CAGR of 8.7%.
- Published: December 2020
- Price: $ 4950
- TOC Available:
-
RFID Antenna Market by Type (Far-field Antenna, Near-field Antenna), Radiation Pattern (Directional, Omnidirectional), Form Factor (Patch/Panel, Gate, Embedded), and Application (Ticketing, Airport & Baggage Handling) - Global Forecast to 2032
The RFID antenna market is projected to reach USD 0.42 billion by 2032 from USD 0.24 billion in 2026, at a CAGR of 10.1% from 2026 to 2032. The report profiles key players such as Zebra Technologies Corp. (US), TE Connectivity (Ireland), SHANGHAI INLAY LINK INC. (INLAYLINK) (China), Nedap N.V. (Netherlands), Kathrein Solutions GmbH (Germany), Pepperl+Fuchs SE (Germany), Times-7 (New Zealand), GAO RFID Inc. (Canada), Impinj, Inc. (US), and Invengo Information Technology Co., Ltd. (China).
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Europe Injectable Drug Delivery Market by Product (Device, Self Injection, Formulation, Solution, Emulsions), Formulation Packaging (Ampoules, Bottles), Therapeutic Application (Obesity, Diabetes, Cancer, Psoriasis), Usage Pattern - Forecast to 2031
The Europe injectable drug delivery market, valued at US$166.13 billion in 2025, stood at US$178.87 billion in 2026 and is projected to advance at a resilient CAGR of 7.7% from 2026 to 2031, culminating in a forecasted valuation of US$259.49 billion by the end of the period. The increasing use of biologics, biosimilars, and long-acting injectables is driving market growth. There is an increasing demand for patient-centric delivery systems and self-administration in major healthcare markets.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Injectable Drug Delivery Market by Product (Device, Autoinjectors, Formulation, Suspensions, Nanoparticles), Site of Administration (Dermal, Organ), Formulation Packaging (Ampoules, Vials), Usage Pattern (Curative, Immunization) - Forecast to 2031
The Asia Pacific injectable drug delivery market, valued at US$161.32 billion in 2025, stood at US$176.96 billion in 2026 and is projected to advance at a resilient CAGR of 9.8% from 2026 to 2031, culminating in a forecasted valuation of US$282.22 billion by the end of the period. The growth of the Asia Pacific injectable drug delivery market is driven by the increasing incorporation of biologics, biosimilars, and long-acting injectables, alongside a rapidly growing patient population and an escalating burden of chronic diseases across major countries in the region.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Polymerase Chain Reaction Market – Usage Pattern and Replacement Trends, End User Analysis, Pricing Analysis, Comparative Analysis, Competitive Landscape Comparative Analysis and End User Preference Study
Polymerase chain reaction (PCR) is one of the revolutionary life science technologies that has not only made tremendous impact on the scientific community, but also affected many aspects of diseases diagnosis and treatment. The overall market for Polymerase chain reaction (PCR) technology has observed steady growth due to the expansion in its application areas and increased accuracy and precision. Specific technology segments of the PCR market, such as dPCR (digital PCR) and qPCR (real-time PCR), are witnessing higher market growth owing to their benefits such as real-time process monitoring, low reagent consumption, automation of workflow, and greater reproducibility and precision.
- Published: March 2016
- Price: $ 4950
- TOC Available:
-
US Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Infectious Diseases, Cancer, Obesity), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), End Users (Hospital, Home Care) - Forecast to 2031
The US injectable drug delivery market, valued at US$285.81 billion in 2025, stood at US$309.90 billion in 2026 and is projected to advance at a resilient CAGR of 8.5% from 2026 to 2031, culminating in a forecasted valuation of US$465.15 billion by the end of the period. The growth of the veterinary contract manufacturing & research market is driven by the increasing adoption of biologics and long-acting injectables, rising demand for patient-centric and self-administration delivery systems, and the need for advanced formulation, device engineering, and scalable manufacturing capabilities.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Diffractive Optical Element Market by Beam Splitter, Pattern Generator, Diffuser, Lenses, Multilevel DOE, AR/VR, LIDAR, Laser Material Processing, Biomedical Devices, Holography, Spectroscopy, Metrology & Industrial Inspection - Global Forecast to 2030
The global diffractive optical element market is expected to grow from USD 220.9 million in 2024 to USD 388.7 million in 2030, at a compound annual growth rate (CAGR) of 9.9% during the forecast period.The key players Zeiss Group (Germany), AGC Inc (Japan), Cohernet Corp (US), Jenoptik (Germany), HOLO/OR Ltd (Israel), Broadcom (US), Nalux Co., Ltd (Japan), Holoeye Photonics AG (Germany), Nissei Technology Corp (Japan), Sintec Optronics Ltd (Singapore).
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Healthcare Virtual Assistants Market by Product (Chatbots, Smart Speakers), User Interface (Automatic Speech Recognition, Text Based, Text-to-Speech Based), End User (Healthcare Providers, Patients, Healthcare Payers) - Global Forecast to 2024
The healthcare virtual assistants market is projected to reach USD 1,729 million by 2024 from USD 391 million in 2019, at a CAGR of 34.6%. Factors such as the growing number of smartphone users and the increasing use of healthcare applications, the growing demand for quality healthcare delivery, and the rising prevalence of chronic disorders are driving the growth of the healthcare virtual assistants market. The increasing focus on developing conversational virtual assistant tools and multi-language support in healthcare virtual assistant tools are also expected to provide growth opportunities for players in the market. Prominent players in the healthcare virtual assistants market are Nuance Communications Inc. (US), Microsoft (US), Amazon (US), Infermedica (Poland), Sensly (US), eGain Corporation (US), Kognito Solutions LLC (US), Verint Systems Inc. (US), HealthTap Inc. (US), and Babylon Healthcare Services Ltd (UK).
- Published: March 2019
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
